Relay Therapeutics RLAY 深 沪
已收盘 09-11 16:00:00 美东时间
18.87
-0.020
-0.11%
华盛通- 最 高19.35
- 今 开19.17
- 成交量 416.44万股
- 最 低 18.675
- 昨 收 18.89
- 总市值 41.35亿
- 52周最高 21.27
- 市盈率 静 --
- 换手率 1.90%
- 52周最低 4.32
- 委 比 -62.28%
- 总股本 2.19亿
- 历史最高 64.37
- 量 比 1.10
- 振 幅 3.57%
- 历史最低 1.775
- 每 手 1
- 风险率 5.02%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 塔吉特获13家大行上调目标价；Moderna携手默沙东齐获大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx Pharmaceutical"超配"评级，目标价从96美元升至103美元；Canaccord Genuity：维持Ultragenyx Pharmaceutical"买入"评级，目标价从81美元升至83美元
08-21 11:40
HC Wainwright & Co. Maintains Buy on Relay Therapeutics, Raises Price Target to $29
HC Wainwright & Co. analyst Robert Burns maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and raises the price target from $28 to $29.
08-20 19:42
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
Barclays Maintains Overweight on Relay Therapeutics, Raises Price Target to $30
Barclays analyst Etzer Darout maintains Relay Therapeutics (NASDAQ:RLAY) with a Overweight and raises the price target from $27 to $30.
08-08 02:58
Relay Therapeutics Expands ATM Equity Offering Agreement
An announcement from Relay Therapeutics ( ($RLAY) ) is now available. On August...
08-07 04:53
Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026
Relay Therapeutics, a clinical-stage precision medicine company, will release its second-quarter 2026 financial results and corporate updates after U.S. markets close on August 6, 2026. The company specializes in developing therapies for cancer and genetic diseases using its Dynamo® platform, which targets previously challenging protein targets. Its lead asset, zovegalisib, is in Phase 3 trials for HR+/HER2- metastatic breast cancer and is being ...
07-30 20:05
美股大行评级 | 富国银行上调亚马逊目标价从313美元升至322美元；潜在涨幅370.99%！HC Wainwright上调Greenwich LifeSciences目标价至69美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Greenwich LifeSciences"买入"评级，目标价从50美元升至69美元；高盛：维持Taysha Gene Therapies"买入"评级，目标价从11美元升至13美元
07-22 11:35
美股大行评级 | 阿斯麦、贝莱德、纽约梅隆银行、信达思、JB亨特运输服务、美国制商银行、PNC金融服务集团等获多家大行集体上调目标价
今日重点评级关注：瑞杰金融：维持Electrovaya"强力买入"评级，目标价从14美元升至22美元；BTIG：维持vTv Therapeutics"买入"评级，目标价从49美元升至57美元
07-17 11:35
Canaccord Genuity Initiates Coverage On Relay Therapeutics with Buy Rating, Announces Price Target of $29
Canaccord Genuity analyst John Newman initiates coverage on Relay Therapeutics (NASDAQ:RLAY) with a Buy rating and announces Price Target of $29.
07-16 18:05
